Global Protein Therapeutics Market Size Study & Forecast, by Product, By Application, and Regional Analysis, 2023-2030

Description

List of Tables

Global Protein Therapeutics Market is valued at approximately USD 325.35 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 7.1% over the forecast period 2023-2030. Protein therapeutics refers to a class of therapeutic agents that are based on proteins or peptides. Proteins are substantial molecules that are crucial for a variety of biological functions, such as immune function, metabolism, and cell signaling. These therapeutic compounds are intended to treat illnesses, disorders, or medical conditions by interacting with certain bodily targets, such as receptors, enzymes, or signaling molecules. The favorable regulatory environment, increase in the geriatric population, and development of the biologics sector, coupled with the rise in healthcare expenditure are the key factors that are spurring the market demand across the globe.

Additionally, the rising prevalence of chronic diseases, such as cancer, diabetes, cardiovascular disorders, and autoimmune diseases is propelling the demand for protein therapeutics during the estimated period. According to National Cancer Institute, in 2018, the number of cancer patients is estimated to account for 18.1 million, which is projected to reach 29.5 million patients by the year 2040. Moreover, the International Diabetic Federation (IDF) reported that in 2021 approximately 537 million adults (20-79 years) are living with diabetes. Also, the total number of people living with diabetes is expected to increase to 643 million by 2030 and 783 million by 2045. Thus, these conditions generally require targeted and personalized treatment approaches like protein therapeutics, which, in turn, augment the market growth at a considerable rate. Furthermore, the rising advancements in biotechnology and protein engineering, as well as the growth in proteomic research present various lucrative opportunities over the forecasting years. However, the high production costs required and the complex manufacturing processes are challenging the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Protein Therapeutics Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing advancements in biotechnology, growing funding for research and development activities, along with the presence of key players in the region. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecasting years. The rapidly growing geriatric population, increasing patient awareness toward protein therapeutics, as well as rising prevalence of chronic diseases are significantly propelling the market demand across the region.

Major market players included in this report are:

Novo Nordisk AS
Baxter International Inc.
Amgen Inc.
Merck and Co., Inc.
Sanofi S.A.
Eli Lilly And Company
Abbott Laboratories
Pfizer Inc.
Johnson and Johnson (Janssen Pharmaceuticals)
F. Hoffmann La Roche Ltd

Recent Developments in the Market:

In December 2022, Enlaza Therapeutics announced the introduction with USD 61 million in financing with the objective of advancing the company's first covalent biologic therapeutic platform. The company integrated novel innovations that allow the introduction of proprietary unnatural amino acids to protein drugs, which allows specific covalent binding to their target proteins.

Global Protein Therapeutics Market Report Scope:

Historical Data - 2020 - 2021
Base Year for Estimation - 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Product, Application, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Monoclonal Antibodies
Insulin
Fusion Protein
Erythropoietin
Interferon
Human Growth Hormone
Follicle Stimulating Hormone

By Application:

Metabolic Disorders
Immunologic Disorders
Cancer
Hormonal Disorders
Genetic Disorders
Others

By Region:

North America

U.S.
Canada

Europe

UK
Germany
France
Spain
Italy
ROE

Asia Pacific

China
India
Japan
Australia
South Korea
RoAPAC

Latin America

Brazil
Mexico

Middle East & Africa

Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
- 1.2.1. Protein Therapeutics Market, by Region, 2020-2030 (USD Billion)
- 1.2.2. Protein Therapeutics Market, by Product, 2020-2030 (USD Billion)
- 1.2.3. Protein Therapeutics Market, by Application, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Protein Therapeutics Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Industry Evolution
- 2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Protein Therapeutics Market Dynamics

3.1. Protein Therapeutics Market Impact Analysis (2020-2030)
- 3.1.1. Market Drivers
  - 3.1.1.1. Development of the biologics sector
  - 3.1.1.2. Rising prevalence of chronic diseases
- 3.1.2. Market Challenges
  - 3.1.2.1. High production costs required
  - 3.1.2.2. Complex manufacturing processes
- 3.1.3. Market Opportunities
  - 3.1.3.1. Rising advancements in biotechnology and protein engineering
  - 3.1.3.2. Growth in proteomic research

Chapter 4. Global Protein Therapeutics Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Protein Therapeutics Market, by Product

5.1. Market Snapshot
5.2. Global Protein Therapeutics Market by Product, Performance - Potential Analysis
5.3. Global Protein Therapeutics Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
5.4. Protein Therapeutics Market, Sub Segment Analysis
- 5.4.1. Monoclonal Antibodies
- 5.4.2. Insulin
- 5.4.3. Fusion Protein
- 5.4.4. Erythropoietin
- 5.4.5. Interferon
- 5.4.6. Human Growth Hormone
- 5.4.7. Follicle Stimulating Hormone

Chapter 6. Global Protein Therapeutics Market, by Application

6.1. Market Snapshot
6.2. Global Protein Therapeutics Market by Application, Performance - Potential Analysis
6.3. Global Protein Therapeutics Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Protein Therapeutics Market, Sub Segment Analysis
- 6.4.1. Metabolic Disorders
- 6.4.2. Immunologic Disorders
- 6.4.3. Cancer
- 6.4.4. Hormonal Disorders
- 6.4.5. Genetic Disorders
- 6.4.6. Others

Chapter 7. Global Protein Therapeutics Market, Regional Analysis

7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Protein Therapeutics Market, Regional Market Snapshot
7.4. North America Protein Therapeutics Market
- 7.4.1. U.S. Protein Therapeutics Market
  - 7.4.1.1. Product breakdown estimates & forecasts, 2020-2030
  - 7.4.1.2. Application breakdown estimates & forecasts, 2020-2030
- 7.4.2. Canada Protein Therapeutics Market
7.5. Europe Protein Therapeutics Market Snapshot
- 7.5.1. U.K. Protein Therapeutics Market
- 7.5.2. Germany Protein Therapeutics Market
- 7.5.3. France Protein Therapeutics Market
- 7.5.4. Spain Protein Therapeutics Market
- 7.5.5. Italy Protein Therapeutics Market
- 7.5.6. Rest of Europe Protein Therapeutics Market
7.6. Asia-Pacific Protein Therapeutics Market Snapshot
- 7.6.1. China Protein Therapeutics Market
- 7.6.2. India Protein Therapeutics Market
- 7.6.3. Japan Protein Therapeutics Market
- 7.6.4. Australia Protein Therapeutics Market
- 7.6.5. South Korea Protein Therapeutics Market
- 7.6.6. Rest of Asia Pacific Protein Therapeutics Market
7.7. Latin America Protein Therapeutics Market Snapshot
- 7.7.1. Brazil Protein Therapeutics Market
- 7.7.2. Mexico Protein Therapeutics Market
7.8. Middle East & Africa Protein Therapeutics Market
- 7.8.1. Saudi Arabia Protein Therapeutics Market
- 7.8.2. South Africa Protein Therapeutics Market
- 7.8.3. Rest of Middle East & Africa Protein Therapeutics Market

Chapter 8. Competitive Intelligence

8.1. Key Company SWOT Analysis
- 8.1.1. Company 1
- 8.1.2. Company 2
- 8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
- 8.3.1. Novo Nordisk AS
  - 8.3.1.1. Key Information
  - 8.3.1.2. Overview
  - 8.3.1.3. Financial (Subject to Data Availability)
  - 8.3.1.4. Product Summary
  - 8.3.1.5. Recent Developments
- 8.3.2. Baxter International Inc.
- 8.3.3. Amgen Inc.
- 8.3.4. Merck and Co., Inc.
- 8.3.5. Sanofi S.A.
- 8.3.6. Eli Lilly And Company
- 8.3.7. Abbott Laboratories
- 8.3.8. Pfizer Inc.
- 8.3.9. Johnson and Johnson (Janssen Pharmaceuticals)
- 8.3.10. F. Hoffmann La Roche Ltd

Chapter 9. Research Process

9.1. Research Process
- 9.1.1. Data Mining
- 9.1.2. Analysis
- 9.1.3. Market Estimation
- 9.1.4. Validation
- 9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Protein Therapeutics Market, report scope
TABLE 2. Global Protein Therapeutics Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Protein Therapeutics Market estimates & forecasts by Product 2020-2030 (USD Billion)
TABLE 4. Global Protein Therapeutics Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 5. Global Protein Therapeutics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 6. Global Protein Therapeutics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Protein Therapeutics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Protein Therapeutics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Protein Therapeutics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Protein Therapeutics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Protein Therapeutics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Protein Therapeutics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Protein Therapeutics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Protein Therapeutics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. U.S. Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 17. U.S. Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. Canada Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. Canada Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. UK Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. UK Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. Germany Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. Germany Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. France Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. France Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. Italy Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. Italy Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Spain Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Spain Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. RoE Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. RoE Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. China Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. China Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. India Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. India Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. Japan Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. Japan Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. South Korea Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. South Korea Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. Australia Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. Australia Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. RoAPAC Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. RoAPAC Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. Brazil Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. Brazil Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Mexico Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Mexico Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. RoLA Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. RoLA Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. Saudi Arabia Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. South Africa Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoMEA Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Protein Therapeutics Market
TABLE 70. List of primary sources, used in the study of global Protein Therapeutics Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

FIG 1. Global Protein Therapeutics Market, research methodology
FIG 2. Global Protein Therapeutics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Protein Therapeutics Market, key trends 2022
FIG 5. Global Protein Therapeutics Market, growth prospects 2023-2030
FIG 6. Global Protein Therapeutics Market, porters 5 force model
FIG 7. Global Protein Therapeutics Market, pest analysis
FIG 8. Global Protein Therapeutics Market, value chain analysis
FIG 9. Global Protein Therapeutics Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Protein Therapeutics Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Protein Therapeutics Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Protein Therapeutics Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Protein Therapeutics Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Protein Therapeutics Market, regional snapshot 2020 & 2030
FIG 15. North America Protein Therapeutics Market 2020 & 2030 (USD Billion)
FIG 16. Europe Protein Therapeutics Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Protein Therapeutics Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Protein Therapeutics Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Protein Therapeutics Market 2020 & 2030 (USD Billion)